Clinical trials
Multiple Sclerosis trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Recruiting | 1 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 8 |
| Actelion | 4 |
| Genzyme, a Sanofi Company | 4 |
| Hoffmann-La Roche | 3 |
| Celgene | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| GeNeuro SA | 2 |
| Merck KGaA, Darmstadt, Germany | 2 |
| Novartis Pharmaceuticals | 2 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 40 |
| Multiple Sclerosis, Relapsing-Remitting | 13 |
| Recurrence | 7 |
| Muscle Spasticity | 2 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Sclerosis | 1 |
| Thinness | 1 |
Trials
Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.